Ratnakar Securities Pvt. Ltd.

EVEREST ORGANICS LTD.

NSE : NABSE : 524790ISIN CODE : INE334C01029Industry : Pharmaceuticals & DrugsHouse : Private

BSE454.9017.75 (+4.06 %)

PREV CLOSE ( ) 437.15

OPEN PRICE ( ) 428.45

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 5864

TODAY'S LOW / HIGH ( )415.05 458.45

52 WK LOW / HIGH ( ) 142.1477

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 19-02 1993

Management Info

Prasad Venkata Satya Sundara Srikakolapu - Chairman Sri Kakarlapudi Sirisha - Managing Director

Registered Office

Address Aroor Village,Sadasivpet Mandal,Sanga Reddy,
Medak Dist,
Telangana-502291

Phone 08455-250186, 250113, 250115

Email eolcs0405@gmail.com

Website www.everestorganicsltd.com

Registrars Details

Venture Capital & Corporate Investments Ltd

Aurum, Door No 4-50/P-II/57/4F&5F Plot No 57,4th & 5th Floors,Jayabheri Enclave Phase - II, Gachibowli,Hyderabad

Listing : BSE

NEWS

17Nov Everest Organics informs about newspap
Pursuant to Regulation 47 of the Securities and Exchange Board of India..

03Oct Everest Organics informs about special
Everest Organics has informed that it enclosed the summary for the month..

06Sep Everest Organics informs about newspap
Pursuant to Regulation 47 of the Securities and Exchange Board of India..

30Aug Everest Organics informs about press r
Everest Organics has informed that it attached copies of the advertiseme..

08Aug Everest Organics informs about press r
Everest Organics has informed that it enclosed copies of the Newspaper A..

Financials

in Millions

	QTR Sep 25	ANNUAL 25
Net Profit	11.5499999999999	-12.8999999999999
Gross Profit	26.7299999999999	-32.4199999999999
Operating Profit	54.1999999999999	79.1000000000001
Net Sales	510.02	1594.79

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Ajanta Pharma (BSE) 2660.70 (0.83%)	M.Cap ( in Cr)33241.62
Venus Remedies (BSE) 763.50 (2.46%)	M.Cap ( in Cr)1020.57
RPG Life Sciences (BSE) 2240.65 (0.53%)	M.Cap ( in Cr)3705.81
Sanjivani Paranteral (BSE) 213.65 (3.99%)	M.Cap ( in Cr)262.45
Astonea Labs (BSE) 154.15 (2.77%)	M.Cap ( in Cr)162.03

Shareholding Pattern

	PROMOTERS	59.64%
	NON-INSTITUTION	40.34%
	FI/BANKS/INSURANCE	0.02%
	MUTUAL FUNDS/UTI	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

attention investors
kyc
ipo
ibt trading
KYC & KRA Status Awareness

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

EVEREST ORGANICS LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES